Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/132901
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Artificial cells for the treatment of liver diseases |
Author: | Zou, D. Wang, H. Liu, X. Xu, Z.P. Roberts, M.S. Zhao, C.X. |
Citation: | Acta Biomaterialia, 2021; 130:98-114 |
Publisher: | Elsevier |
Issue Date: | 2021 |
ISSN: | 1742-7061 1878-7568 |
Statement of Responsibility: | Da Zou, Haolu Wang, Xin Liu, Zhi Ping Xu, Michael S.Roberts, Chun-Xia Zhao |
Abstract: | Liver diseases have become an increasing health burden and account for over 2 million deaths every year globally. Standard therapies including liver transplant and cell therapy offer a promising treatment for liver diseases, but they also suffer limitations such as adverse immune reactions and lack of long-term efficacy. Artificial cells that mimic certain functions of a living cell have emerged as a new strategy to overcome some of the challenges that liver cell therapy faces at present. Artificial cells have demonstrated advantages in long-term storage, targeting capability, and tuneable features. This article provides an overview of the recent progress in developing artificial cells and their potential applications in liver disease treatment. First, the design of artificial cells and their biomimicking functions are summarized. Then, systems that mimic cell surface properties are introduced with two concepts highlighted: cell membrane-coated artificial cells and synthetic lipid-based artificial cells. Next, cell microencapsulation strategy is summarized and discussed. Finally, challenges and future perspectives of artificial cells are outlined. STATEMENT OF SIGNIFICANCE: Liver diseases have become an increasing health burden. Standard therapies including liver transplant and cell therapy offer a promising treatment for liver diseases, but they have limitations such as adverse immune reactions and lack of long-term efficacy. Artificial cells that mimic certain functions of a living cell have emerged as a new strategy to overcome some of the challenges that liver cell therapy faces at present. This article provides an overview of the recent progress in developing artificial cells and their potential applications in liver disease treatment, including the design of artificial cells and their biomimicking functions, two systems that mimic cell surface properties (cell membrane-coated artificial cells and synthetic lipid-based artificial cells), and cell microencapsulation strategy. We also outline the challenges and future perspectives of artificial cells. |
Keywords: | Artificial cell biomimetic cell therapy liver diseases |
Rights: | © 2021 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved. |
DOI: | 10.1016/j.actbio.2021.06.012 |
Grant ID: | http://purl.org/au-research/grants/nhmrc/1126091 http://purl.org/au-research/grants/nhmrc/1141121 http://purl.org/au-research/grants/arc/FT140100726 http://purl.org/au-research/grants/arc/DP200101238 |
Published version: | http://dx.doi.org/10.1016/j.actbio.2021.06.012 |
Appears in Collections: | Chemical Engineering publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.